MedPath

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

Not Applicable
Recruiting
Conditions
Smokeless Tobacco
Registration Number
NCT07107139
Lead Sponsor
Roswell Park Cancer Institute
Brief Summary

This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age ≥ 21 years of age
  • Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)
  • Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year
  • Open to trying a non-combusted oral tobacco product
  • Have the ability to read, write, and communicate in English
  • Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus > $0
  • Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (<8ppm)
  • Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.
Exclusion Criteria
  • Age ≥ 21 years of age
  • Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)
  • Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year
  • Open to trying a non-combusted oral tobacco product
  • Have the ability to read, write, and communicate in English
  • Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus > $0
  • Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (<8ppm) .
  • Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Change in sensory responseBefore viewing study ads and immediatley after viewing

assessed with a 0-100 visual analog scale - anchored by word descriptors at each end.

Secondary Outcome Measures
NameTimeMethod
Change in nicotine boostWill be collected after 5, 15 and 30 minutes of product use.

Will be measured after use of products with gas chromatography-mass spectrometry

Trial Locations

Locations (1)

Roswell Park

🇺🇸

Buffalo, New York, United States

Roswell Park
🇺🇸Buffalo, New York, United States
ask rpci
Contact
877-275-7724
askrpci@roswellpark.org
Richard O'Connor, PHD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.